The PennZone

  • Home
  • Business
  • Health
  • Technology
  • Non-profit
  • Financial
  • Services
  • Entertainment
  • Construction

New Version of HLN's Award Winning Open Source Immunization Forecaster Released
The PennZone/10055828

Trending...
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Men's Health Network Highlights Major 2025 Achievements & Launches New Donation Platform For Greater Impact
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
Sample ICE Patient Evaluation and Forecast NVPO UpShot Award HLN Consulting, LLC
Innovative open source software, originally developed for public health, is freely available to EHR and PHR systems to support clinical decision support for immunizations.

PALM DESERT, Calif. - PennZone -- On February 12, 2020, HLN released a new version (v1.22.1) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open-source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR) and Personal Health Record (PHR) Systems.

This version includes important updates including:
  • Logic updates to the Pneumococcal Vaccine Group following the latest ACIP guidance.
  • Logic corrections for the DTP Vaccine Group and Influenza Vaccine Group.
  • A minor modification to how month-based calculations are performed.
  • More user-friendly wording for the evaluation reason text and recommendation reason text.
  • A new option which, when enabled, returns the supplemental text for evaluations and recommendations where applicable. For the appropriate pneumococcal recommendations, ICE utilizes this feature to return supplemental text that recommends shared clinical decision making, and cites the relevant MMWR.
  • A new option which, when enabled, allows client applications to override how ICE would normally evaluate a specified shot (i.e., client applications can indicate that an administered immunization being submitted to ICE for evaluation must be treated as INVALID or VALID per an input parameter).
  • ICE now outputs the version of the ICE service in each response.

The full software release is available for download at https://cdsframework.atlassian.net/wiki/display/ICE/Downloads.

More on The PennZone
  • UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
  • 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
  • Tickeron Launches Next-Gen AI Corridor Bots: Consistent Exits for Stocks and ETFs
  • From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."

The Immunization Calculation Engine, or ICE, is a fully configurable vaccine forecasting/decision support web service tool. Making patient-specific vaccine decisions based on US Government American Council on Immunization Practices (ACIP) clinical recommendations is a very complex task. It requires translating ACIP recommendations - the detailed rules that examine a patient's immunization history and determine if all vaccinations are valid, and what vaccinations might be missing - into computable language for clinical decision support. ICE evaluates a patient's immunization history and generates the appropriate immunization recommendations for the patient. These recommendations are communicated to the clinician at the point of care, as well as the patient, health department or other users.

In developing ICE, HLN worked with the New York City Citywide Immunization Registry (CIR), the Alabama Department of Public Health, and the OpenCDS collaboration which is led by researchers at the University of Utah, Department of Biomedical Informatics. ICE is now in use or being configured for use by several governmental Immunization Information Systems (including in the states of Michigan, New Jersey, Rhode Island, and Vermont, as well as New York City), electronic health record (EHR) systems (including eClinicalWorks, some Centricity sites, and the Indian Health Service's RPMS), the AZOVA Digital Health Marketplace, and the CareDox personal health record. Other EHRs, personal health record (PHR) systems, and Health Information Exchanges (HIEs) can be easily adapted to incorporate ICE logic and clinical decision support into their systems as well.

More on The PennZone
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • Canterbury Hotel Group Announces the Opening of the TownePlace Suites by Marriott Portland Airport
  • Heritage at South Brunswick's Resort-Style Amenities for Any Age and Every Lifestyle
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • Hummell Brothers Celebrates 100 Years as Trusted Lighting Store in Jeannette

Please feel free to e-mail ice@hln.com if you have any questions.

About HLN

For more than twenty years, HLN has been a leading public health informatics consulting company focused on developing and supporting robust technical solutions addressing pressing public health needs. HLN is dedicated to the development, improvement, promulgation, and use of Open Source solutions in health information technology. Much of our Open Source work is focused on clinical decision support (CDS) applications built using OpenCDS, an open source clinical decision support platform, including our Immunization Calculation Engine (ICE) and Reportable Condition Knowledge Management System (RCKMS) which is supporting the national strategy of electronic case reporting to public health. RCKMS is being funded by the Centers for Disease Control and Prevention (CDC) through the Council of State and Territorial Epidemiologists (CSTE) and deployed centrally to determine if a patient's symptoms and conditions require reporting to one or more public health jurisdiction.

More information on HLN Consulting and its open source products can be found at https://www.hln.com.

Contact
Noam H. Arzt, PhD
arzt@hln.com
8585382220


Source: HLN Consulting, LLC
Filed Under: Health

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • Explosive Growth in U.S. Cryptocurrency Cloud Mining Sets The Stage for New Platform Launch with Daily Rewards in a Transparent Revenue-Share Model
  • Qtex Cierra Ronda de $7 Millones para Estandarizar la Banca Transfronteriza en los Mercados Emergentes de Latinoamérica
  • Ring in the Season with Free Holiday Jazz from The Jazz Sanctuary
  • America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
  • Signature Smiles Dental Group Unveils New User-Friendly Website
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
  • QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
  • Local Holistic Consultant Pharmacist Featured on National Podcast as FDA Updates Hormone Therapy Safety
  • 100% Bonus Depreciation Places New Spotlight on Off The Hook Yacht Sales Inc. (N Y S E: OTH) as a Major Player in the $57 Billion U.S. Marine Market
  • CNCPW Benchmarks Global Industry Standards: Integrating SEC Compliance with 3 Million TPS Architecture for Institutional Infrastructure
  • The Patina Collective & Artist Jesse Draxler Debut "The Machine of Loving Grace"
  • Smile! Dental Center Named 2025 "Best Dentist" in North Pittsburgh, Celebrating High-Tech Care and Heartfelt Service
  • Dr. Johnny Shanks, As Seen on TV, Announces 20% Off Dental Implant Treatments | Tennessee's Leading All-on-X Provider
  • Star Sleep & Wellness Expands to Pearland, Texas — Bringing Life-Changing Sleep Care to More Communities

Popular on PennZone

  • Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 427
  • BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers - 186
  • Light Her Way Launches New Cohort of Board of AdviseHERS to Prepare Women for Board-Ready Leadership
  • 5,000 Australians Call for Clarity: NaturismRE's Petition Reaches Major Milestone
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • BITE Data raises $3m to build AI tools for global trade compliance teams
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • purelyIV Expands Wellness Services with Flu/COVID Testing and Menopause Coaching & Treatment
  • CCHR Supports Call to End Coercive Psychiatry at World Mental Health Congress

Similar on PennZone

  • Melospeech Inc. Accepts Nomination for HealthTech Startup of the Year
  • "Dr. Vincent Michael Malfitano Expands Monterey–Sicily Cultural Diplomacy With Major International Media Engagement"
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
  • High-Conviction CNS Disruptor Aiming to Transform Suicidal Depression, Ketamine Therapeutics, and TMS - Reaching Millions by 2030
  • OKAVA Pharmaceuticals Announces First Cat Dosed in MEOW-1 Study of OKV-119, the World's First Clinical-Stage GLP-1 Weight-Loss Therapy for Pets
  • FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
  • "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
  • Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
  • Signature Smiles Dental Group Unveils New User-Friendly Website
  • CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us